BridgeMD
New treatment option for Hair Transplantation
Official title A Study on Scalp Health and Integrated Scalp Management Protocols for Hair Transplant Patients
ClinicalTrials.gov ID: NCT07641686
What this study is testing
- What it's testing
- A total of 120 Chinese male subjects aged 18-50 years who have undergone hair transplantation are planned to be enrolled in this study. Among them, 90 participants with mild-to-moderate scalp seborrheic dermatitis (hereinafter abbreviated as SD) will be stratified and randomly allocated into two groups based on a randomization table with stratification factors including SD severity grading, alopecia classification and age.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55, men only. Healthy volunteers may be eligible.
You may be able to join if
- Healthy Chinese male people aged between 18 and 55 years old;
- Diagnosed with androgenetic alopecia, with alopecia grade from Grade II to Grade VI per Hamilton-Norwood classification;
- Scheduled to receive hair transplantation; scalp condition is confirmed suitable for trial participation by dermatologist assessment after hair graft...
- With or without mild-to-moderate scalp seborrheic dermatitis (SD score ranging from 0 to 9);
- No anti-dandruff shampoo used within the latest 14 days prior to enrollment;
You likely can't join if
- Suffering from severe scalp seborrheic dermatitis;
- Received oral or topical antifungal drugs, glucocorticoids or other therapeutic medicines for seborrheic dermatitis within the preceding 30 days;
- Complicated with other scalp diseases (such as psoriasis), or with obvious infection or unhealed wounds on the target treatment area;
- Known hypersensitivity to ingredients including selenium disulfide, salicylic acid and related components;
- History of autoimmune diseases or severe organic diseases involving heart, brain, lung, liver, kidney and other vital organs;
- Past medical history of psychiatric or psychological disorders;
See the full eligibility criteria
- Healthy Chinese male people aged between 18 and 55 years old;
- Diagnosed with androgenetic alopecia, with alopecia grade from Grade II to Grade VI per Hamilton-Norwood classification;
- Scheduled to receive hair transplantation; scalp condition is confirmed suitable for trial participation by dermatologist assessment after hair graft surgery;
- With or without mild-to-moderate scalp seborrheic dermatitis (SD score ranging from 0 to 9);
- No anti-dandruff shampoo used within the latest 14 days prior to enrollment;
- No hair dyeing, perming or hair styling cosmetic treatments in the past 30 days;
- Able to comply with all scheduled study visits;
- Possess normal communication and comprehension capacity;
- Agree to regular follow-up visits and complete related questionnaires on time;
- Fully understand trial procedures, volunteer to join the study and provide written informed consent.
- Suffering from severe scalp seborrheic dermatitis;
- Received oral or topical antifungal drugs, glucocorticoids or other therapeutic medicines for seborrheic dermatitis within the preceding 30 days;
- Complicated with other scalp diseases (such as psoriasis), or with obvious infection or unhealed wounds on the target treatment area;
- Known hypersensitivity to ingredients including selenium disulfide, salicylic acid and related components;
- History of autoimmune diseases or severe organic diseases involving heart, brain, lung, liver, kidney and other vital organs;
- Past medical history of psychiatric or psychological disorders;
- Refuse to sign the written informed consent form;
- Currently enrolled in another treatment clinical trial;
- Diagnosed with alopecia areata, pseudopelade, cicatricial alopecia or other scalp and hair disorders;
- Have taken part in any other clinical trial within the prior 3 months;
- Judged as inappropriate for trial participation based on investigator's clinical assessment.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years to 55 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.